» Articles » PMID: 36661517

Protective Effect of Vitamin D Against Hepatic Molecular Apoptosis Caused by a High-Fat Diet in Rats

Overview
Publisher MDPI
Specialty Molecular Biology
Date 2023 Jan 20
PMID 36661517
Authors
Affiliations
Soon will be listed here.
Abstract

The protective effects of vitamin D (VitD) in different diseases were studied. The liver is of great interest, especially with the presence of VitD receptors. A high-fat diet (HFD) is associated with many diseases, including liver injury. Consumption of saturated fatty acids triggers hepatic apoptosis and is associated with increased inflammation. We aimed in this study to investigate the protective effects of VitD on hepatic molecular apoptotic changes in response to an HFD in rats. Forty male Wistar albino rats were used and divided into four groups: control, HFD, control + VitD, and VitD-supplemented HFD (HFD + VitD) groups. After six months, the rats were sacrificed, and the livers were removed. RNA was extracted from liver tissues and used for the quantitative real-time RT-PCR of different genes: B-cell lymphoma/leukemia-2 (BCL2), BCL-2-associated X protein (Bax), Fas cell surface death receptor (FAS), FAS ligand (FASL), and tumor necrosis factor α (TNF-α). The results showed that an HFD increased the expression of the pro-apoptotic genes Bax, FAS, and FASL, and reduced the expression of the anti-apoptotic gene BCL2. Interestingly, a VitD-supplemented HFD significantly increased the BCL2 expression and decreased the expression of all pro-apoptotic genes and TNFα. In conclusion, VitD has a protective role against hepatic molecular apoptotic changes in response to an HFD.

Citing Articles

The role of inflammation induced by necroptosis in the development of fibrosis and liver cancer in novel knockin mouse models fed a western diet.

Selvarani R, Nguyen H, Pazhanivel N, Raman M, Lee S, Wolf R Geroscience. 2024; .

PMID: 39514172 DOI: 10.1007/s11357-024-01418-3.


Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives.

Drapkina O, Elkina A, Sheptulina A, Kiselev A Int J Mol Sci. 2023; 24(9).

PMID: 37176153 PMC: 10178980. DOI: 10.3390/ijms24098445.

References
1.
Wang H, Zhang Q, Chai Y, Liu Y, Li F, Wang B . 1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats. J Endocrinol Invest. 2015; 38(10):1083-91. PMC: 4768236. DOI: 10.1007/s40618-015-0287-6. View

2.
Vieth R . Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol. 2004; 89-90(1-5):575-9. DOI: 10.1016/j.jsbmb.2004.03.038. View

3.
Li Z, Berk M, McIntyre T, Gores G, Feldstein A . The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology. 2008; 47(5):1495-503. PMC: 3025414. DOI: 10.1002/hep.22183. View

4.
Pobezinskaya Y, Liu Z . The role of TRADD in death receptor signaling. Cell Cycle. 2012; 11(5):871-6. PMC: 3679287. DOI: 10.4161/cc.11.5.19300. View

5.
Cosentino N, Campodonico J, Milazzo V, De Metrio M, Brambilla M, Camera M . Vitamin D and Cardiovascular Disease: Current Evidence and Future Perspectives. Nutrients. 2021; 13(10). PMC: 8541123. DOI: 10.3390/nu13103603. View